Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.540
-0.100 (-6.10%)
At close: Feb 21, 2025, 4:00 PM
1.530
-0.010 (-0.65%)
After-hours: Feb 21, 2025, 7:59 PM EST
PACB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | - | -306.74 | -314.25 | -181.22 | 29.4 | |
| Depreciation & Amortization | - | 26.53 | 17.32 | 11.59 | 9.3 | |
| Other Amortization | - | - | - | - | 0.13 | |
| Loss (Gain) From Sale of Investments | - | -12.84 | -0.24 | 4.01 | -0.11 | |
| Stock-Based Compensation | - | 72.12 | 78.61 | 73.36 | 17.53 | |
| Other Operating Activities | - | 20.71 | 9.32 | -39.24 | -33.47 | |
| Change in Accounts Receivable | - | -17.83 | 5.46 | -7.17 | -1.6 | |
| Change in Inventory | - | -13.84 | -33.91 | -13.11 | -1.62 | |
| Change in Accounts Payable | - | 0.21 | 1.03 | 6.36 | -5.07 | |
| Change in Unearned Revenue | - | -10.42 | -3.73 | 25.74 | 0.73 | |
| Change in Other Net Operating Assets | - | -17.07 | -22.81 | 8.5 | 4.28 | |
| Operating Cash Flow | - | -259.17 | -263.21 | -111.18 | 19.5 | |
| Capital Expenditures | - | -8.84 | -16.75 | -5.93 | -1.04 | |
| Cash Acquisitions | - | -0.1 | - | -319.79 | - | |
| Sale (Purchase) of Intangibles | - | - | -0.18 | - | - | |
| Investment in Securities | - | 13.55 | 133.01 | -352.81 | -218.28 | |
| Investing Cash Flow | - | 4.6 | 116.08 | -678.53 | -219.32 | |
| Long-Term Debt Issued | - | - | - | 895.54 | - | |
| Long-Term Debt Repaid | - | -1.84 | -1.61 | -0.36 | -16 | |
| Net Debt Issued (Repaid) | - | -1.84 | -1.61 | 895.18 | -16 | |
| Issuance of Common Stock | - | 204.52 | 11.23 | 326.65 | 233.84 | |
| Other Financing Activities | - | -93.79 | - | -52.25 | 34 | |
| Financing Cash Flow | - | 108.89 | 9.62 | 1,170 | 251.84 | |
| Net Cash Flow | - | -145.68 | -137.51 | 379.87 | 52.02 | |
| Free Cash Flow | - | -268.02 | -279.96 | -117.11 | 18.46 | |
| Free Cash Flow Margin | - | -133.66% | -218.20% | -89.73% | 23.40% | |
| Free Cash Flow Per Share | - | -1.06 | -1.25 | -0.57 | 0.11 | |
| Cash Interest Paid | - | 15.69 | 14.05 | 6.93 | 0.49 | |
| Levered Free Cash Flow | - | -306.52 | 48.82 | -24.54 | -39.58 | |
| Unlevered Free Cash Flow | - | -297.56 | 58 | -16.71 | -39.54 | |
| Change in Net Working Capital | 45.41 | 195.53 | -167.19 | -8.26 | 0.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.